Benjamin Uberti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Benjamin Uberti has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Gabriel Morán
Austral University of Chile, Valdivia, Chile, Chile
12 shared publications - Claudio Henríquez
Austral University of Chile, Valdivia, Chile, Chile
8 shared publications Natalia Morales
Universidad Austral de Chile
5 shared publicationsClaudio Henriquez
Universidad Austral de Chile
4 shared publications- Gonzalo Gajardo
Escuela de Graduados, Facultad de Ciencias Veterinarias, Universidad Austral de Chile, Valdivia, Chile
4 shared publications - Anita Plaza
Instituto de Medicina, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile
3 shared publications
Latest Publications
- 6 May 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (1) , 157-164
Changes in measurable ultrasonographic parameters in growing Arabian foals from birth to 1 year
Background: Utrasonographic measurements of the abdominal viscera and the heart in growing Arabian foals have not been described. Objectives: To establish normal intervals for ultrasonographic measurements of cardiac indices and abdominal viscera in growing Arabian foals from birth to 1 year of age. Study Design: Prospective longitudinal descriptive study. Methods: Ultrasonographic images were captured from 15 foals every 3 months from 1 week to 1 year of age. During each examination, at least three images were obtained at each location and measurements were obtained using standardised ultrasonographic approaches. Reference intervals were established for 11 indices of abdominal viscera (left and right kidney length, width and cortical thickness; left and right caudal aorta diameter, caecal wall thickness and vasculature diameter; and stomach wall thickness) and 11 cardiac indices (pulmonary artery diameter at end‐diastole, aortic diameter at end‐diastole, left atrial diameter at end‐diastole, right ventricular internal diameter at end‐diastole, interventricular septal thickness at end‐diastole, interventricular septal thickness at peak‐systole, left ventricular internal diameter at end‐diastole, left ventricular internal diameter at peak‐systole, left ventricular free wall thickness at end‐diastole, left ventricular free wall thickness at peak‐systole and fractional shortening). Results: All abdominal structures grew in size from the first week of life up to 1 year of age. All cardiac variables, except for interventricular septal thickness at end‐diastole and fractional shortening, increased with age up to 1 year. No sex differences were detected. Main Limitations: Small sample size. Conclusions: This study provides age‐appropriate reference intervals for several ultrasonographically visible structures in Arabian foals up to 1 year of age. This information is essential for clinical management and decision‐making in this sub‐population of equine patients.
- 6 May 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (1) , 157-164
Changes in measurable ultrasonographic parameters in growing Arabian foals from birth to 1 year
Background: Utrasonographic measurements of the abdominal viscera and the heart in growing Arabian foals have not been described. Objectives: To establish normal intervals for ultrasonographic measurements of cardiac indices and abdominal viscera in growing Arabian foals from birth to 1 year of age. Study Design: Prospective longitudinal descriptive study. Methods: Ultrasonographic images were captured from 15 foals every 3 months from 1 week to 1 year of age. During each examination, at least three images were obtained at each location and measurements were obtained using standardised ultrasonographic approaches. Reference intervals were established for 11 indices of abdominal viscera (left and right kidney length, width and cortical thickness; left and right caudal aorta diameter, caecal wall thickness and vasculature diameter; and stomach wall thickness) and 11 cardiac indices (pulmonary artery diameter at end‐diastole, aortic diameter at end‐diastole, left atrial diameter at end‐diastole, right ventricular internal diameter at end‐diastole, interventricular septal thickness at end‐diastole, interventricular septal thickness at peak‐systole, left ventricular internal diameter at end‐diastole, left ventricular internal diameter at peak‐systole, left ventricular free wall thickness at end‐diastole, left ventricular free wall thickness at peak‐systole and fractional shortening). Results: All abdominal structures grew in size from the first week of life up to 1 year of age. All cardiac variables, except for interventricular septal thickness at end‐diastole and fractional shortening, increased with age up to 1 year. No sex differences were detected. Main Limitations: Small sample size. Conclusions: This study provides age‐appropriate reference intervals for several ultrasonographically visible structures in Arabian foals up to 1 year of age. This information is essential for clinical management and decision‐making in this sub‐population of equine patients.
- 1 March 2025
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 147, 105397
Diagnosis and treatment of a congenital cervical tracheal diverticulum in an Arabian foal
- 1 March 2025
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 147, 105397
Diagnosis and treatment of a congenital cervical tracheal diverticulum in an Arabian foal
- Open Access
- 20 November 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (11) , e0313783
Treatment approaches to horses with acute diarrhea admitted to referral institutions: A multicenter retrospective study
Background: This study aimed to describe and compare therapeutic approaches for horses with acute diarrhea in different geographic regions worldwide. Methods: Clinical information was retrospectively collected from diarrheic horses presented to participating institutions between 2016 and 2020, including fluid therapy on admission, antimicrobial drugs, probiotics, anti-endotoxic medications, anti-inflammatory drugs, gastroprotectants, digital cryotherapy, and toxin-binding agents. Seasonal and geographic differences were investigated. Results: 1438 horses from 26 participating hospitals from 5 continents were included. On admission, 65% (926/1419) of horses were administered a fluid bolus. Antimicrobial drugs were administered to 55% (792/1419) within the first 24 hours of admission, with penicillin and gentamicin being the most used combination (25%, 198/792). Horses with leukopenia (OR: 2.264, 95%CI: 1.754 to 2.921; P<0.001) or meeting systemic inflammatory response syndrome criteria (OR: 2.542, 95%CI: 1.919 to 3.368; P<0.001) had higher odds of being administered antimicrobial drugs. Other treatments administered included probiotics (15%, 215/1438), polymyxin B (13%; 187/1438), pentoxifylline (8%; 118/1438), gastroprotectants (44%; 626/1419), digital cryotherapy (34%; 489/1435), plasma transfusion (13%; 182/1410) and toxin-binding agents (36%; 515/1438). Limitations: Due to the retrospective nature of the study, the rationale for treatment decisions was unavailable, and associations with survival could not be evaluated. Conclusions: Treatments varied between hospitals from different geographic regions. Prospective clinical trials are required to evaluate the effects of various treatments on survival.
- 20 November 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (11) , e0313783
Open AccessTreatment approaches to horses with acute diarrhea admitted to referral institutions: A multicenter retrospective study
Background: This study aimed to describe and compare therapeutic approaches for horses with acute diarrhea in different geographic regions worldwide. Methods: Clinical information was retrospectively collected from diarrheic horses presented to participating institutions between 2016 and 2020, including fluid therapy on admission, antimicrobial drugs, probiotics, anti-endotoxic medications, anti-inflammatory drugs, gastroprotectants, digital cryotherapy, and toxin-binding agents. Seasonal and geographic differences were investigated. Results: 1438 horses from 26 participating hospitals from 5 continents were included. On admission, 65% (926/1419) of horses were administered a fluid bolus. Antimicrobial drugs were administered to 55% (792/1419) within the first 24 hours of admission, with penicillin and gentamicin being the most used combination (25%, 198/792). Horses with leukopenia (OR: 2.264, 95%CI: 1.754 to 2.921; P<0.001) or meeting systemic inflammatory response syndrome criteria (OR: 2.542, 95%CI: 1.919 to 3.368; P<0.001) had higher odds of being administered antimicrobial drugs. Other treatments administered included probiotics (15%, 215/1438), polymyxin B (13%; 187/1438), pentoxifylline (8%; 118/1438), gastroprotectants (44%; 626/1419), digital cryotherapy (34%; 489/1435), plasma transfusion (13%; 182/1410) and toxin-binding agents (36%; 515/1438). Limitations: Due to the retrospective nature of the study, the rationale for treatment decisions was unavailable, and associations with survival could not be evaluated. Conclusions: Treatments varied between hospitals from different geographic regions. Prospective clinical trials are required to evaluate the effects of various treatments on survival.
- Open Access
Andrographolide Inhibits Expression of NLPR3 Inflammasome in Canine Mononuclear Leukocytes
Inflammasomes are multiprotein complexes that trigger processes through caspase-1 activation, leading to the maturation of proinflammatory cytokines, such as IL-1β and IL-18. The gene encoding the inflammasome stimulatory protein NLRP3 is conserved in canines. Caspase-1/4 homologues have been identified in multiple carnivores, including canines, and caspase-1 activity has been shown in humans. The NLRP3 inflammasome has also been described in some canine inflammatory diseases. Andrographolide, a labdane diterpene, is the principal active ingredient in the herb Andrographis paniculate. The objective of this study was to determine the effect of andrographolide on the gene expression of the components of the NLRP3 inflammasome, proinflammatory cytokines, and IL-1β secretion in canine peripheral blood mononuclear cells. For this, MTT assays and real-time PCR were employed to assess the cytotoxicity and gene expression. Further, an ELISA test was performed to measure the IL-1β concentration. The findings reveal that andrographolide significantly reduces the expression of NLRP3, caspase-1/4, IL-1β, and IL-18. Additionally, it decreases the secretion of IL-1β and other proinflammatory cytokines, including IL-6, IL-8, and TNF-α. The results show that andrographolide decreases the expression of NLRP3, caspase-1/4, IL-1β, and IL-18. Andrographolide also reduces proinflammatory cytokines expression, and decreases IL-1β secretion. This indicates that andrographolide can interfere with the activation and function of the inflammasome, resulting in a decrease in the inflammatory response in canines. Research in this area is still budding, and more studies are necessary to fully understand andrographolide’s mechanisms of action and its therapeutic potential in relation to the NLRP3 inflammasome in dogs.
Open AccessAndrographolide Inhibits Expression of NLPR3 Inflammasome in Canine Mononuclear Leukocytes
Inflammasomes are multiprotein complexes that trigger processes through caspase-1 activation, leading to the maturation of proinflammatory cytokines, such as IL-1β and IL-18. The gene encoding the inflammasome stimulatory protein NLRP3 is conserved in canines. Caspase-1/4 homologues have been identified in multiple carnivores, including canines, and caspase-1 activity has been shown in humans. The NLRP3 inflammasome has also been described in some canine inflammatory diseases. Andrographolide, a labdane diterpene, is the principal active ingredient in the herb Andrographis paniculate. The objective of this study was to determine the effect of andrographolide on the gene expression of the components of the NLRP3 inflammasome, proinflammatory cytokines, and IL-1β secretion in canine peripheral blood mononuclear cells. For this, MTT assays and real-time PCR were employed to assess the cytotoxicity and gene expression. Further, an ELISA test was performed to measure the IL-1β concentration. The findings reveal that andrographolide significantly reduces the expression of NLRP3, caspase-1/4, IL-1β, and IL-18. Additionally, it decreases the secretion of IL-1β and other proinflammatory cytokines, including IL-6, IL-8, and TNF-α. The results show that andrographolide decreases the expression of NLRP3, caspase-1/4, IL-1β, and IL-18. Andrographolide also reduces proinflammatory cytokines expression, and decreases IL-1β secretion. This indicates that andrographolide can interfere with the activation and function of the inflammasome, resulting in a decrease in the inflammatory response in canines. Research in this area is still budding, and more studies are necessary to fully understand andrographolide’s mechanisms of action and its therapeutic potential in relation to the NLRP3 inflammasome in dogs.
- 6 July 2023
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 128, 104881
Relationship Between Selenium, Copper, Zinc and Their Biomarkers in Blood and Skeletal Muscle Tissue in Adult Horses From Southern Chile
- 6 July 2023
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 128, 104881
Relationship Between Selenium, Copper, Zinc and Their Biomarkers in Blood and Skeletal Muscle Tissue in Adult Horses From Southern Chile
- Open Access
- 16 March 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 806069
Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species
Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an in vitro immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates in vivo, cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.
- 16 March 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 806069
Open AccessPre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species
Mesenchymal stem/stromal cells (MSCs) therapy has been a cornerstone of regenerative medicine in humans and animals since their identification in 1968. MSCs can interact and modulate the activity of practically all cellular components of the immune response, either through cell-cell contact or paracrine secretion of soluble mediators, which makes them an attractive alternative to conventional therapies for the treatment of chronic inflammatory and immune-mediated diseases. Many of the mechanisms described as necessary for MSCs to modulate the immune/inflammatory response appear to be dependent on the animal species and source. Although there is evidence demonstrating an in vitro immunomodulatory effect of MSCs, there are disparate results between the beneficial effect of MSCs in preclinical models and their actual use in clinical diseases. This discordance might be due to cells' limited survival or impaired function in the inflammatory environment after transplantation. This limited efficacy may be due to several factors, including the small amount of MSCs inoculated, MSC administration late in the course of the disease, low MSC survival rates in vivo, cryopreservation and thawing effects, and impaired MSC potency/biological activity. Multiple physical and chemical pre-conditioning strategies can enhance the survival rate and potency of MSCs; this paper focuses on hypoxic conditions, with inflammatory cytokines, or with different pattern recognition receptor ligands. These different pre-conditioning strategies can modify MSCs metabolism, gene expression, proliferation, and survivability after transplantation.
- Open Access
- 20 October 2020
- Published by Springer Nature in Research Square
Evaluation of Peripheral Blood Neutrophil Functions after an Oral Carbohydrate Overload in Obese and Insulin Resistant Horses
Background: Obesity and insulin resistance (IR) are conditions of increasing prevalence in populations of equids worldwide. The immune impairment described in metabolic dysfunction status in humans has been extensively reported with minimal data regarding horses. The objective of the study was to evaluate the effect of obesity as an isolated factor and in association with insulin resistance on apoptosis, phagocytosis and oxidative burst activity of neutrophils isolated from peripheral blood of lean and obese adult horses with or without insulin resistance, basally and after induction of hyperglycemia through an oral glucose test. Results: No differences in apoptosis were observed between experimental groups at any time point. Phagocytic capacity was significantly diminished at baseline in the obese-IR group (PConclusions: Results from this study showed that both metabolic status itself, and acute hyperglycemia, are factors that influence PMNs functionality in horses, specifically phagocytosis and oxidative burst. This indicates the need for close monitoring of immune function in horses with inflammatory disease and concurrent obesity and insulin resistance.
- 20 October 2020
- Published by Springer Nature in Research Square
Open AccessEvaluation of Peripheral Blood Neutrophil Functions after an Oral Carbohydrate Overload in Obese and Insulin Resistant Horses
Background: Obesity and insulin resistance (IR) are conditions of increasing prevalence in populations of equids worldwide. The immune impairment described in metabolic dysfunction status in humans has been extensively reported with minimal data regarding horses. The objective of the study was to evaluate the effect of obesity as an isolated factor and in association with insulin resistance on apoptosis, phagocytosis and oxidative burst activity of neutrophils isolated from peripheral blood of lean and obese adult horses with or without insulin resistance, basally and after induction of hyperglycemia through an oral glucose test. Results: No differences in apoptosis were observed between experimental groups at any time point. Phagocytic capacity was significantly diminished at baseline in the obese-IR group (PConclusions: Results from this study showed that both metabolic status itself, and acute hyperglycemia, are factors that influence PMNs functionality in horses, specifically phagocytosis and oxidative burst. This indicates the need for close monitoring of immune function in horses with inflammatory disease and concurrent obesity and insulin resistance.
- 1 October 2020
- Published by Elsevier in Research in Veterinary Science
- Vol. 132, 127-132
Assessment of peripheral blood neutrophil respiratory burst, phagocytosis and apoptosis in obese non-insulin dysregulated horses
- 1 October 2020
- Published by Elsevier in Research in Veterinary Science
- Vol. 132, 127-132
Assessment of peripheral blood neutrophil respiratory burst, phagocytosis and apoptosis in obese non-insulin dysregulated horses
- Open Access
- 17 June 2020
- Published by Wiley in Veterinary Medicine and Science
- Vol. 6 (4) , 673-678
Tamoxifen and its metabolites induce mitochondrial membrane depolarization and caspase‐3 activation in equine neutrophils
Neutrophils participate in innate immunity as the first line of host defence against microorganisms. However, persistent neutrophil activity and delayed apoptosis can be harmful to surrounding tissues; this problem occurs in diverse inflammatory diseases, including asthma‐affected horses. Previous studies in horses with acute lung inflammation indicated that treatment with tamoxifen (TX), a selective oestrogen receptor modulator, produces a significant decrease in bronchoalveolar lavage fluid (BALF) neutrophil content. The aim of this study was to investigate the effect of tamoxifen and its metabolites (N‐desmethyltamoxifen and endoxifen) on the mitochondrial membrane potential assay by flow cytometry, and the activation of effector caspase‐3 through immunoblotting, in peripheral blood neutrophils obtained from healthy horses (n = 5). Results show that tamoxifen, N‐desmethyltamoxifen and endoxifen depolarize the mitochondrial membrane and activate caspase‐3 in healthy equine neutrophils in vitro. These findings suggest that tamoxifen and its metabolites may activate the intrinsic apoptotic pathway in equine neutrophils. However, more studies are necessary to further explore the signalling pathways of these drugs in the induction of apoptosis.
- 17 June 2020
- Published by Wiley in Veterinary Medicine and Science
- Vol. 6 (4) , 673-678
Open AccessTamoxifen and its metabolites induce mitochondrial membrane depolarization and caspase‐3 activation in equine neutrophils
Neutrophils participate in innate immunity as the first line of host defence against microorganisms. However, persistent neutrophil activity and delayed apoptosis can be harmful to surrounding tissues; this problem occurs in diverse inflammatory diseases, including asthma‐affected horses. Previous studies in horses with acute lung inflammation indicated that treatment with tamoxifen (TX), a selective oestrogen receptor modulator, produces a significant decrease in bronchoalveolar lavage fluid (BALF) neutrophil content. The aim of this study was to investigate the effect of tamoxifen and its metabolites (N‐desmethyltamoxifen and endoxifen) on the mitochondrial membrane potential assay by flow cytometry, and the activation of effector caspase‐3 through immunoblotting, in peripheral blood neutrophils obtained from healthy horses (n = 5). Results show that tamoxifen, N‐desmethyltamoxifen and endoxifen depolarize the mitochondrial membrane and activate caspase‐3 in healthy equine neutrophils in vitro. These findings suggest that tamoxifen and its metabolites may activate the intrinsic apoptotic pathway in equine neutrophils. However, more studies are necessary to further explore the signalling pathways of these drugs in the induction of apoptosis.